Evidence map›Paper›PMID 28117936›Full record

ReviewAngewandte Chemie (International ed. in English)2017

Protein-Templated Fragment Ligations-From Molecular Recognition to Drug Discovery.

Mike Jaegle, Ee Lin Wong, Carolin Tauber, Eric Nawrotzky, Christoph Arkona, Jörg Rademann

Open access · greenAbstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Templated Generation of a Bcl-xChemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Fragment-based covalent ligand discovery.RSC chemical biology · 2021
    Review
  17. Article
  18. Protein-Templated Hit Identification through an Ugi Four-Component Reaction*.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mike JaegleFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.
Ee Lin WongFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.
Carolin TauberFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.
Eric NawrotzkyFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.
Christoph ArkonaFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.
Jörg RademannFreie Universität Berlin, Medicinal Chemistry, Königin-Luise-Strasse 2+4, Berlin, 14195, Germany.ORCID 0000-0001-6678-3165
Freie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-templated fragment ligation is a novel concept to support drug discovery and can help to improve the efficacy of protein ligands. Protein-templated fragment ligations are chemical reactions between small molecules ("fragments") utilizing a protein's surface as a reaction vessel to catalyze the formation of a protein ligand with increased binding affinity. The approach exploits the molecular recognition of reactive small-molecule fragments by proteins both for ligand assembly and for the identification of bioactive fragment combinations. In this way, chemical synthesis and bioassay are integrated in one single step. This Review discusses the biophysical basis of reversible and irreversible fragment ligations and gives an overview of the available methods to detect protein-templated ligation products. The chemical scope and recent applications as well as future potential of the concept in drug discovery are reviewed.

Indexed as

Biophysical PhenomenaCrystallography, X-RayDrug DiscoveryLigandsMagnetic Resonance SpectroscopyProtein BindingProteinsLigandsProteinsdynamic covalent chemistryfragment-based drug discoveryhigh-throughput screeningmolecular recognitionprotein-templated reactions

Identifiers

PMID28117936
PMCPMC7159684
OpenAlexW2582322962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.